Xaira exec divulges R&D focus, how $1B fundraise fuels AI-driven hunt for what the ‘industry is hungriest for’ March 19, 2026
Xaira Therapeutics Launches X-Cell, Its First Virtual Cell Model, Trained on the Largest-Ever Genome-Wide Perturbation Dataset, X-Atlas/Pisces March 18, 2026
